---
title: Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like
  protein (ASH2L) as a regulator of glioblastoma cell survival
date: '2023-11-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37974198/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231117170704&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Together, we suggest that targeting ASH2L could serve as
  a new therapeutic opportunity for glioblastoma. Video ...'
disable_comments: true
---
CONCLUSION: Together, we suggest that targeting ASH2L could serve as a new therapeutic opportunity for glioblastoma. Video ...